| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.01 | 0.8 |